-
61
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
Published 2021-09-01Subjects: “…myelodysplastic syndromes…”
Get full text
Article -
62
-
63
Cardiovascular risk in elderly Egyptians with myelodysplastic syndromes
Published 2024-01-01Subjects: “…Myelodysplastic syndromes (MDS)…”
Get full text
Article -
64
Discovering transcription and splicing networks in myelodysplastic syndromes.
Published 2013-01-01“…Then, we applied this method to investigate the mechanism of myelodysplastic syndromes (MDS), a precursor lesion of acute myeloid leukemia. …”
Get full text
Article -
65
Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
Published 2021-01-01Subjects: “…hypoplastic myelodysplastic syndrome…”
Get full text
Article -
66
Myelodysplastic syndrome: epidemiology, diagnostics and epigenetic disorders
Published 2022-07-01Subjects: Get full text
Article -
67
BMT for Myelodysplastic Syndrome: When and Where and How
Published 2022-01-01Subjects: “…myelodysplastic syndromes…”
Get full text
Article -
68
The Effects of Genetic Characteristics on the Survival in Myelodysplastic Syndrome
Published 2022-02-01Subjects: “…myelodysplastic syndromes…”
Get full text
Article -
69
Cytogenetic profile in patients with primary myelodysplastic syndrome
Published 2013-07-01Subjects: “…de novo myelodysplastic syndrome…”
Get full text
Article -
70
The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
Published 2022-10-01“…Genomic instability, microenvironmental aberrations, and somatic mutations contribute to the phenotype of myelodysplastic syndrome and the risk for transformation to AML. …”
Get full text
Article -
71
Myelodysplastic syndromes: therapeutic problems and decisions (review)
Published 2014-07-01Subjects: “…myelodysplastic syndromes…”
Get full text
Article -
72
Role of reactive oxygen species in myelodysplastic syndromes
Published 2024-04-01Subjects: Get full text
Article -
73
When karyotype is decisive for myelodysplastic syndromes diagnosis
Published 2019-10-01“…Introduction: The myelodysplastic syndromes (MDS) are a group of heterogeneous clonal hematopoietic stem cell disorders that results in peripheral blood (PB) cytopenias and bone marrow (BM) dysplasia. …”
Get full text
Article -
74
Cytophagic Histiocytic Panniculitis Associated with Myelodysplastic Syndrome
Published 2018-09-01Get full text
Article -
75
Management of patients with lower-risk myelodysplastic syndromes
Published 2022-12-01“…Abstract Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell disorders characterized by ineffective hematopoiesis with abnormal blood cell development (dysplasia) leading to cytopenias and an increased risk for progression to acute myeloid leukemia (AML). …”
Get full text
Article -
76
Novel combinations to improve hematopoiesis in myelodysplastic syndrome
Published 2020-03-01Subjects: “…Myelodysplastic syndrome…”
Get full text
Article -
77
Extracellular Vesicles and MicroRNA in Myelodysplastic Syndromes
Published 2023-02-01Subjects: Get full text
Article -
78
-
79
-
80
The role of azacitidine in the management of myelodysplastic syndromes (MDS)
Published 2009-10-01“…Current data on azacitidine and its place in the treatment of MDS are reviewed.Keywords: myelodysplastic syndromes, MDS, azacitidine, epigenetic therapy, demethyltransferase inhibitor…”
Get full text
Article